IVF Hartmann H1 FY26 EBIT climbs 27.5% to CHF 12.07 million; revenue increases 11.3% to CHF 85.9 million

Reuters2026/08/12 04:41

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

IVF Hartmann posted first-half 2026 revenue up 11.3% to CHF 85.9 million; EBIT rose 27.5% to CHF 12.1 million.
EBIT margin widened 1.7 percentage points to 14%; net profit climbed 24.7% to CHF 10.3 million.
Growth was driven by market-share gains and temporary customer stockpiling tied to economic uncertainty; cost and supplier management stayed tight.
Segment revenue rose 13.9% to CHF 34.3 million in infection management; incontinence management increased 13.8% to CHF 20.6 million.
For 2026, it expects revenue and EBIT above 2025, while flagging weaker second-half growth as stockpiling effects fade.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IVF Hartmann Holding AG published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

IVF Hartmann H1 FY26 EBIT climbs 27.5% to CHF 12.07 million; revenue increases 11.3% to CHF 85.9 million

You may also like

Crypto prices